<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="105" ids="17234">Glucose</z:chebi> metabolism is altered in various pathologic conditions in the brain, i. e. <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, <z:e sem="disease" ids="C0014544" disease_type="Disease or Syndrome" abbrv="">epilepsy</z:e> and <z:hpo ids='HP_0001943'>hypoglycemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Therefore, analysis of <z:chebi fb="105" ids="17234">glucose</z:chebi> metabolism in pathologic conditions needs careful investigation of that in steady state </plain></SENT>
<SENT sid="2" pm="."><plain><z:chebi fb="18" ids="36928">13C</z:chebi>-NMR method allows continuous sequential monitoring of changes in metabolism of <z:chebi fb="105" ids="17234">glucose</z:chebi> in vivo </plain></SENT>
<SENT sid="3" pm="."><plain>The natural abundance of <z:chebi fb="18" ids="36928">13C</z:chebi> is quite low (1.1%) and by administering <z:chebi fb="18" ids="36928">13C</z:chebi> labelled in various skeleton in <z:chebi fb="105" ids="17234">glucose</z:chebi>, it is possible to monitor the metabolites in vivo </plain></SENT>
<SENT sid="4" pm="."><plain>In this study, <z:chebi fb="18" ids="36928">13C</z:chebi> <z:chebi fb="105" ids="17234">glucose</z:chebi> labelled in 1-position of carbon was employed to investigate the metabolic pathways in the control and transient ischemic gerbil brain with reperfusion </plain></SENT>
<SENT sid="5" pm="."><plain>Male mongolian gerbils weighing 60-80 g were employed in this study </plain></SENT>
<SENT sid="6" pm="."><plain>The gerbils were anesthetized by intraperitoneal administration of <z:chebi fb="0" ids="7983">pentobarbital</z:chebi> </plain></SENT>
<SENT sid="7" pm="."><plain>The right skull was exposed and a surface coli was placed directly above the skull bone </plain></SENT>
<SENT sid="8" pm="."><plain>After the operation, the animals were fastened to the NMR probe vertically </plain></SENT>
<SENT sid="9" pm="."><plain>500 mg/kg of [1-13C] <z:chebi fb="105" ids="17234">glucose</z:chebi> was injected via femoral catheter </plain></SENT>
<SENT sid="10" pm="."><plain><z:chebi fb="18" ids="36928">13C</z:chebi>-NMR spectra were serially obtained before and after injection with GX-270 NMR spectrometer (JEOL, Tokyo, Japan, 6.34 T) </plain></SENT>
<SENT sid="11" pm="."><plain>In other series of experiments, 30 minutes of <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> were induced after 15 minutes of <z:chebi fb="105" ids="17234">glucose</z:chebi> injection by the bilateral common carotid <z:mp ids='MP_0006134'>artery occlusion</z:mp> </plain></SENT>
<SENT sid="12" pm="."><plain>In the <z:mpath ids='MPATH_458'>normal</z:mpath> gerbil brain, after administration of [1-13C] <z:chebi fb="105" ids="17234">glucose</z:chebi> (500 mg/kg), alpha and beta-anomers of [1-13C] <z:chebi fb="105" ids="17234">glucose</z:chebi> peak appeared abruptly and reached its peak level at 7.5-15 min acquisition period </plain></SENT>
<SENT sid="13" pm="."><plain>The C2 peak representing <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> and/or glutamine appeared later </plain></SENT>
<SENT sid="14" pm="."><plain>The C3 and C4 peak started to appear even later at 30-40 min.(ABSTRACT TRUNCATED AT 250 WORDS) </plain></SENT>
</text></document>